Tag Archive for: risks

The European Union’s drug regulator will this week consider wider use of Novo Nordisk’s weight-loss drug Wegovy to include reducing the risk of strokes and heart attacks.

Thursday’s FDA advisory committee rejection is the latest regulatory defeat for the company’s drug-device combo. The panel found that the benefits of the treatment did not outweigh its risks.

Upcoming regulatory changes surrounding the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) have been making headlines across the globe. As the United States and European Union continue to move toward banning and limiting the use of PFAS products, the pharmaceutical industry, much like others, must address the mounting risks related to this family of chemicals.